scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1032142D |
P356 | DOI | 10.1371/JOURNAL.PONE.0132142 |
P932 | PMC publication ID | 4489013 |
P698 | PubMed publication ID | 26132557 |
P5875 | ResearchGate publication ID | 279731848 |
P50 | author | Sylvain Dubucquoi | Q56807887 |
David Launay | Q56850551 | ||
Vincent Sobanski | Q57082921 | ||
P2093 | author name string | Patrick Vermersch | |
Didier Lefranc | |||
Cédric Broussard | |||
Philippe Chafey | |||
Lionel Prin | |||
Sophie Duban-Deweer | |||
Patricia Dussart | |||
Virginie Dutoit-Lefèvre | |||
P2860 | cites work | Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis | Q24813085 |
Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease | Q28185679 | ||
A rapid screening assay to search for phosphorylated proteins in tissue extracts | Q28485206 | ||
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose | Q29617478 | ||
Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis | Q30836381 | ||
Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. | Q30902170 | ||
New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. | Q31083807 | ||
Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis | Q33203611 | ||
Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis | Q33243817 | ||
Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis. | Q33253142 | ||
Proteome analysis of maize pollen for allergy-relevant components | Q33262422 | ||
Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma | Q33262742 | ||
CyDye immunoblotting for proteomics: co-detection of specific immunoreactive and total protein profiles | Q33263914 | ||
Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology | Q33267301 | ||
Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease | Q79895188 | ||
Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach | Q80607190 | ||
Proteomics-based identification of human acute leukemia antigens that induce humoral immune response | Q81007996 | ||
A combined SDS-PAGE and proteomics approach to identify target autoantigens in healthy individuals and patients with autoimmune diseases | Q81038476 | ||
Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis | Q81244222 | ||
Vitiligo Autoantigen VIT75 Is Identified as Lamin A in Vitiligo by Serological Proteome Analysis Based on Mass Spectrometry | Q82491945 | ||
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease. | Q51764633 | ||
Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. | Q54474404 | ||
Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach | Q56978208 | ||
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis | Q57267912 | ||
Identification of antibodies as biological markers in serum from multiple sclerosis patients by immunoproteomic approach | Q57279619 | ||
Identification of new celiac disease autoantigens using proteomic analysis | Q59653130 | ||
Staphylococcus aureus proteins differentially recognized by the ovine immune response in mastitis or nasal carriage | Q60550793 | ||
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis | Q74405612 | ||
Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis | Q79705725 | ||
Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis | Q33324701 | ||
Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). | Q33329447 | ||
Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes | Q33417857 | ||
Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis | Q33489237 | ||
Immunoscreening of the extracellular proteome of colorectal cancer cells | Q33534464 | ||
Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV) | Q33775443 | ||
Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches | Q33865598 | ||
Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis | Q33899085 | ||
Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria | Q34221892 | ||
Staphylococcus aureus seroproteomes discriminate ruminant isolates causing mild or severe mastitis | Q34639298 | ||
Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers | Q35018525 | ||
Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection | Q35536190 | ||
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach | Q35557980 | ||
Cancer immunomics using autoantibody signatures for biomarker discovery | Q36766125 | ||
Comparative proteomics and difference gel electrophoresis | Q37077435 | ||
SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification | Q37817215 | ||
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections | Q37857721 | ||
Comparative proteomic analysis of blood eosinophils reveals redox signaling modifications in patients with FIP1L1-PDGFRA-associated chronic eosinophilic leukemia | Q39596035 | ||
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system. | Q39642376 | ||
Detection of tyrosine phosphorylated proteins by combination of immunoaffinity enrichment, two-dimensional difference gel electrophoresis and fluorescent Western blotting | Q39648970 | ||
Identification of melanoma antigens using a Serological Proteome Approach (SERPA). | Q39735634 | ||
Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement | Q39760458 | ||
Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. | Q39953442 | ||
Serological immunoreactivity against colon cancer proteome varies upon disease progression | Q40027849 | ||
Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray | Q40030353 | ||
Autoantibody signature in human ductal pancreatic adenocarcinoma. | Q40083640 | ||
Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. | Q40165870 | ||
An efficient proteomics-based approach for the screening of autoantibodies. | Q40417822 | ||
Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses | Q40664080 | ||
Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis | Q42555303 | ||
Novel autoantigens in autoimmune hypophysitis | Q42642337 | ||
Identification of novel autoantigens by a triangulation approach | Q42702963 | ||
Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation | Q43471150 | ||
Identification of tumor antigens in renal cell carcinoma by serological proteome analysis | Q43705985 | ||
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma | Q44291842 | ||
Antibodies in patients with neuropsychiatric systemic lupus erythematosus | Q44583325 | ||
Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes | Q45263012 | ||
Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. | Q46622407 | ||
Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. | Q46752407 | ||
Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. | Q47305429 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
P304 | page(s) | e0132142 | |
P577 | publication date | 2015-07-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies | |
P478 | volume | 10 |